Evidence for Clonally Associated Increasing Rates of Azithromycin Resistant Neisseria gonorrhoeae in Rio de Janeiro, Brazil

BioMed Research International
Késia T Barros Dos SantosRaquel Regina Bonelli

Abstract

Azithromycin is one of the drugs used in the combined therapy for syndromic treatment of gonorrhoea in many countries, including Brazil. Our research group, which receives isolates from clinical laboratories since 2006, has detected, after 2016, a tendency of rising rates of azithromycin resistance, with isolates showing higher minimal inhibitory concentrations (MICs) than those previously reported in this country. In this study, we report the susceptibility to azithromycin of 93 N. gonorrhoeae isolates obtained between 2014 and 2017. Strains with MIC ≥2 μg/mL were characterized according to azithromycin resistance mechanisms and strain typing. Results indicate that azithromycin resistance has emerged in all these years in unrelated MLST-STs, but after 2016 a clonal complex connected with ST1901 has been more frequently detected, grouping isolates with MIC varying from 2 to 64 μg/mL, with DelA mutations at the mtrR promoter region associated or not with mutations at rrl alleles. High rates of azithromycin resistance may compromise the use of this drug in the combined therapy with ceftriaxone. Inclusion of Rio de Janeiro in the Brazilian gonococcal surveillance program is important to evaluate if this data indicates an epidemiol...Continue Reading

References

Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Lai-King NgLouis Bryden
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·Sydney L CousinMarilyn C Roberts
Jun 30, 2010·Antimicrobial Agents and Chemotherapy·Stephanie A ChisholmCatherine A Ison
Nov 26, 2010·Antimicrobial Agents and Chemotherapy·Vanessa G AllenRoberto G Melano
Jan 5, 2011·Emerging Infectious Diseases·Makoto OhnishiJo Kitawaki
Jul 2, 2014·Clinical Microbiology Reviews·Magnus Unemo, William M Shafer
Jul 30, 2017·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Ana Paula Ramalho da Costa-LourençoRaquel Regina Bonelli
Dec 12, 2017·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Ana Paula Ramalho da Costa-LourençoRaquel Regina Bonelli
Mar 11, 2018·The Lancet Infectious Diseases·Magnus Unemo, Kimberly Workowski

❮ Previous
Next ❯

Citations

Aug 15, 2019·Memórias do Instituto Oswaldo Cruz·Rafael Affini MartinsAntonio Carlos Campos Pignatari

❮ Previous
Next ❯

Datasets Mentioned

BETA
FA1090

Methods Mentioned

BETA
Electrophoresis
PCR

Software Mentioned

Bionumerics
Biomerics

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Ana Paula Ramalho da Costa-LourençoRaquel Regina Bonelli
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Dong-mei WangMing-xiang Zou
© 2022 Meta ULC. All rights reserved